{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-14T12:27:05.368117+00:00",
  "news": [
    {
      "title": "Amgen (NASDAQ:AMGN) Downgraded to \"Hold\" Rating by Freedom Capital - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNbGJKc1ZkUHB6d3YybEhXSEZqMUNWdnBkdE42NXJsd0ZqdVZkTGlwUmROaW9pTFV2aVhBTFQxRGFfLW9pN3dNanlOOWVvQk9tWll1Tnd3WXpXYkg3YUZnR20wMGlXY1o1N0xsQk4zNElBZEZBVXRzaF9QM2JHT0NVVzZYNFFCN0dhZm90V2s0Q2xvWUQzVkZ5SWFuS0l2THpwV25adC1EOUhqaTg0d0Z6SXd6UXBvZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxNbGJKc1ZkUHB6d3YybEhXSEZqMUNWdnBkdE42NXJsd0ZqdVZkTGlwUmROaW9pTFV2aVhBTFQxRGFfLW9pN3dNanlOOWVvQk9tWll1Tnd3WXpXYkg3YUZnR20wMGlXY1o1N0xsQk4zNElBZEZBVXRzaF9QM2JHT0NVVzZYNFFCN0dhZm90V2s0Q2xvWUQzVkZ5SWFuS0l2THpwV25adC1EOUhqaTg0d0Z6SXd6UXBvZw?oc=5\" target=\"_blank\">Amgen (NASDAQ:AMGN) Downgraded to \"Hold\" Rating by Freedom Capital</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-14T11:41:05+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT - Yahoo Finance Singapore",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQNzVJaEJBQmxnaUNRTDVkWEluNGk2MWNURkhnZldLR21YbG9rYVRwa1Z0Y3BuVlRLcVRyRzdjRlB2MDhoQVdlVHZzWWRPWVRyVHFtOWVZTHNIVjVKazFnZWZ3MUp3U2N4UU5MbzVyUGRLUXNBYzN3MUZab2ZUUVFwZThJekFPck85?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQNzVJaEJBQmxnaUNRTDVkWEluNGk2MWNURkhnZldLR21YbG9rYVRwa1Z0Y3BuVlRLcVRyRzdjRlB2MDhoQVdlVHZzWWRPWVRyVHFtOWVZTHNIVjVKazFnZWZ3MUp3U2N4UU5MbzVyUGRLUXNBYzN3MUZab2ZUUVFwZThJekFPck85?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance Singapore</font>",
      "published": "2026-02-13T21:01:00+00:00",
      "source": "Yahoo Finance Singapore"
    },
    {
      "title": "Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQTXFlWXR6MTdvdkFvdThTZkdadGxnaUNiOG9Qa1RRTzFyR1ExOGI1Q1IxODhBT3NOUmpRblcxN0tKNkl0azFpcHZ5MVY0eEliRkxDeE1DUTQ2OWRJdUtCMWFLM0NLVUVjbEdGV3VHNEdDXzA1TjdHbEJPLVZqN0pTaFRXM1YzN1dqNkNxUkRoTlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTXFlWXR6MTdvdkFvdThTZkdadGxnaUNiOG9Qa1RRTzFyR1ExOGI1Q1IxODhBT3NOUmpRblcxN0tKNkl0azFpcHZ5MVY0eEliRkxDeE1DUTQ2OWRJdUtCMWFLM0NLVUVjbEdGV3VHNEdDXzA1TjdHbEJPLVZqN0pTaFRXM1YzN1dqNkNxUkRoTlE?oc=5\" target=\"_blank\">Decoding Amgen Inc (AMGN): A Strategic SWOT Insight</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-02-14T05:53:46+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "How to watch Amgen at Citi's 2026 virtual oncology summit - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTNGd0dUM2NQNWRFWmRCRlBnU0t0cGVzY1djTmh0Q1RRUkJnRWthMk1tTnRNbHZpOTZ5amdkdGRVbHNhOVMwUTZvYk1vUlJ2NnVzNW5scXJkRUtwNGMxSUsycml4QWtEQUpLdXYzekprbGtpU2Y5ZXVEZ0dIS2pYeXNjTlhzMFNDZDA4LU1neEk5d2l1NFM0Si1uLVYtVndkOFRZSUN0LXhLcnE4UU5FcmsxUVk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTNGd0dUM2NQNWRFWmRCRlBnU0t0cGVzY1djTmh0Q1RRUkJnRWthMk1tTnRNbHZpOTZ5amdkdGRVbHNhOVMwUTZvYk1vUlJ2NnVzNW5scXJkRUtwNGMxSUsycml4QWtEQUpLdXYzekprbGtpU2Y5ZXVEZ0dIS2pYeXNjTlhzMFNDZDA4LU1neEk5d2l1NFM0Si1uLVYtVndkOFRZSUN0LXhLcnE4UU5FcmsxUVk?oc=5\" target=\"_blank\">How to watch Amgen at Citi's 2026 virtual oncology summit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2026-02-13T21:01:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen wins new EU approval for Uplizna in gMG - European Pharmaceutical Review",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNVdrSkFRb01GOW9CVmRQakg5dFh6aW5GWEFJWmY1NnBhUzIyVXVKejFkU0daLTBuSHBnWUpQOC1QaHdwd1dEMjE1enlxQ2djS2dseFRZVlZSVkpBVFhRS0hiTXJTUGxFbUkxa0RUWWJrVXpBRHNIVEVORW1OU05kWDJpYU1BRl9iZWN3MkdkQk5CLU9oSnRCVkt1eUwta280MlJGcEQzWWdnUERKS2xRamlDQUMwTWlEZWZj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNVdrSkFRb01GOW9CVmRQakg5dFh6aW5GWEFJWmY1NnBhUzIyVXVKejFkU0daLTBuSHBnWUpQOC1QaHdwd1dEMjE1enlxQ2djS2dseFRZVlZSVkpBVFhRS0hiTXJTUGxFbUkxa0RUWWJrVXpBRHNIVEVORW1OU05kWDJpYU1BRl9iZWN3MkdkQk5CLU9oSnRCVkt1eUwta280MlJGcEQzWWdnUERKS2xRamlDQUMwTWlEZWZj?oc=5\" target=\"_blank\">Amgen wins new EU approval for Uplizna in gMG</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">European Pharmaceutical Review</font>",
      "published": "2026-02-13T17:36:49+00:00",
      "source": "European Pharmaceutical Review"
    },
    {
      "title": "Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5\" target=\"_blank\">Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-02-03T08:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN",
      "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQMWdvRF9KMVIyTTVEeHB4MFhIMzlNeWhfZFNrdXhiQlJoR2NHNUlMVmpaMXZSblFSUnBKM0N0dWVJazktcnExX2JLa0luNEVGdUpWQnFHRG5zVlJzX1NOX1hLTXVVaFhGdHE3TlBaN3N0d2hsNGNrV0UtRnhsZzRaNkxlX3pUZlRicFVaMldXdk95NmxlbWZGQjJWWkoxa1RndmZyR2dod19uUHJhOExpTzlLUXhZbUd4NWhFOTJ6NmZFM3p1ZXc2MTMwY05yNjFkTGRkS0xJaXhycXlQWm96MXFSTHAxQmpu?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQMWdvRF9KMVIyTTVEeHB4MFhIMzlNeWhfZFNrdXhiQlJoR2NHNUlMVmpaMXZSblFSUnBKM0N0dWVJazktcnExX2JLa0luNEVGdUpWQnFHRG5zVlJzX1NOX1hLTXVVaFhGdHE3TlBaN3N0d2hsNGNrV0UtRnhsZzRaNkxlX3pUZlRicFVaMldXdk95NmxlbWZGQjJWWkoxa1RndmZyR2dod19uUHJhOExpTzlLUXhZbUd4NWhFOTJ6NmZFM3p1ZXc2MTMwY05yNjFkTGRkS0xJaXhycXlQWm96MXFSTHAxQmpu?oc=5\" target=\"_blank\">Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-02-13T15:40:41+00:00",
      "source": "MSN"
    },
    {
      "title": "AMGEN INC SEC 10-K Report - TradingView",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5\" target=\"_blank\">AMGEN INC SEC 10-K Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2026-02-13T21:15:01+00:00",
      "source": "TradingView"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN INC SEC 10-K Report - TradingView",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5\" target=\"_blank\">AMGEN INC SEC 10-K Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2026-02-13T21:15:01+00:00",
      "source": "TradingView"
    },
    {
      "title": "Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5\" target=\"_blank\">Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-04T03:18:16+00:00",
      "source": "TipRanks"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-01T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-02-13",
      "close": 369.19000244140625
    },
    "history": [
      {
        "date": "2026-02-05",
        "close": 365.26898193359375
      },
      {
        "date": "2026-02-06",
        "close": 381.6753234863281
      },
      {
        "date": "2026-02-09",
        "close": 373.23382568359375
      },
      {
        "date": "2026-02-10",
        "close": 362.1406555175781
      },
      {
        "date": "2026-02-11",
        "close": 364.057373046875
      },
      {
        "date": "2026-02-12",
        "close": 363.6800231933594
      },
      {
        "date": "2026-02-13",
        "close": 369.19000244140625
      }
    ],
    "name": "Amgen Inc."
  }
}